KALA vs LULU · $54.3M cap vs P/E 17, rev $11.10B
Kala Pharmaceuticals Inc (KALA) versus Lululemon Athletica Inc. (LULU) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported LULU revenue for 2026-02-01 was $11.10B. Net income was $1.58B. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
KALA currently screens at market cap $54.3M. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Not investment advice. Open the KALA and LULU stock pages for the full models.
Not investment advice.